Detalhe da pesquisa
1.
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
Br J Cancer
; 114(5): 505-9, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26867157
2.
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.
BMJ Support Palliat Care
; 13(3): 354-362, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807048
3.
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Neurooncol Adv
; 5(1): vdad124, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841696
4.
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.
BMJ Open
; 12(9): e058107, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104135
5.
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
Neuro Oncol
; 23(10): 1736-1749, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984151
6.
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study.
BMJ Open
; 11(12): e054075, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185327